Overview

A Study To Evaluate The Effect Of Rifampin On Pharmacokinetics Of PF-06463922 In Healthy Volunteers

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the effect of rifampin on the single dose PK of PF-06463922.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Rifampin